Announced Mon, 22 Jun · 19:57 IST
Gland Pharma schedules analyst meeting on June 25, 2026
Board & Shareholder Meetings View source PDF
GLAND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+6.3%1-day move
₹2184.90
prior close
₹2193.30
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+2.1+2.4+2.2+2.0+6.3+5.9+8.5+13.3+13.3+12.4+12.8+9.3——
Up moveDown movePending
AI summary
Gland Pharma has informed the exchanges about its schedule of analyst and institutional investor meetings. On June 25, 2026, the company will hold one-on-one meetings with Ambit PMS, arranged by B&K and 360One. The disclosure is made under SEBI Listing Regulations. The company noted the schedule may change due to exigencies on either side. This is a routine compliance filing about investor engagement, with no operational or financial details shared.
Likely market impact
Routine disclosure of investor meetings; no material business update. Watch for any post-meeting insights or management commentary that may move the stock.